ELAN | tickerfilter.com

Fundamental analysis

23%

Profitability 25%

Dept financing 11%

Liquidity 75%

Performance 12%

Company vs Stock growth

+ Add row to compare

Performance

5 Days

-5.76%

1 Month

1.97%

3 Months

13.14%

6 Months

42.42%

1 Year

130.37%

2 Year

53.87%

Key data

Stock price

$24.88

P/E Ratio

0.00

DAY RANGE

$24.52 - $25.48

EPS

-$0.47

52 WEEK RANGE

$8.02 - $27.72

52 WEEK CHANGE

$129.31

MARKET CAP

11.244 B

YIELD

N/A

SHARES OUTSTANDING

497.168 M

DIVIDEND

N/A

EX-DIVIDEND DATE

N/A

NEXT EARNINGS DATE

08-07-2025

BETA

1.12

PUBLIC FLOAT

AVERAGE 10 VOLUME

$5,134,204

AVERAGE 30 VOLUME

$4,695,929

Company detail

CEO: Jeffrey N. Simmons
Region: US
Website: elanco.com
Employees: 9,800
IPO year: 2018

Issue type: Common Stock
Market: NYSE
Industry: Pharmaceutical Products/Pharmaceutical Preparations
Sector: Manufacturing

Elanco Animal Health Incorporated offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks. The company sells its products to third-party distributors; veterinarians; and farm animal producers, including beef and dairy farmers.

ELAN - Elanco Animal Health Inc